Evaluation of efficacy and safety of lanthanum carbonate in hyperphosphatemia patients on dialysis with either 2.5 or 3.0 mEq/L of dialysate calcium concentration

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2009
INTERVENTION: Lanthanum carbonate treatment CONDITION: Maintenance hemodialysis patients with hyperphosphatemia PRIMARY OUTCOME: Serum phosphate, serum calcium and serum Ca x P product level and intact‐PTH SECONDARY OUTCOME: Adverse events, drug compliance INCLUSION CRITERIA: 1) Hemodialysis pts 2) Hyperphosphatemia pts treated with phosphate binder or hyperphosphatemia pts needed to start phosphate binder treatment
Epistemonikos ID: c5639afc1ef5011f35be37f2fe8de048452c193f
First added on: Aug 22, 2024